This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
105 |
4. Check minimum number of eventsNone |
105 |
5. Include endpointsNone |
105 |
6. Filter based on genotype QC (FinnGen only) |
105 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 105 | 31 | 74 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.03 |
| Median age at first event (years) | 68.79 | 61.29 | 71.94 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
15
19
9.04
11.31
1.8
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
33
626
0.31
7.32
3.3
5.3
mmol/l
2.4
2.5
0.38
28
561
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
36
618
0.36
5.67
4.3
5.0
mmol/l
5.7
6.2
2.75
30
537
(40761511) CBC panel - Blood by Automated count
43
663
0.40
4.85
23.0
14.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
6
12.37
4.34
1.1
1.2
g/l
38.5
26.4
—
7
6
(3009508) Creatinine [Moles/volume] in Urine
6
217
0.23
4.13
2.2
3.1
mmol/l
6.2
7.3
—
6
183
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
27
486
0.40
4.09
3.1
3.7
pmol/l
15.3
14.9
0.36
27
420
(40768806) Pleura Pathology biopsy report
6
5
12.60
3.81
1.3
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
6
10.50
3.54
1.2
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
30
497
0.45
3.46
31.4
18.0
%
14.3
13.9
0.85
30
480
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
10
7.40
3.42
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
330
0.36
3.41
1.6
2.1
pmol/l
87.3
89.6
—
7
174
(3009542) Hematocrit [Volume Fraction] of Blood
36
555
0.47
3.38
24.9
16.4
%
36.9
38.7
0.83
25
328
(3041096) Erythrocytes [Presence] in Urine by Automated
5
174
0.25
3.22
2.8
3.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
29
471
0.47
3.01
4.3
4.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
20
371
0.43
2.94
3.5
3.0
u/l
47.1
49.8
0.07
20
334
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
7
13
5.68
2.92
2.7
1.2
u/ml
62.7
87.8
—
7
13
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
15
310
0.40
2.86
3.2
2.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
15
308
0.40
2.80
7.7
4.2
ug/l
2.8
2.5
0.16
15
265
(3044889) 12 lead EKG panel
31
453
0.55
2.02
4.0
4.1
—
—
—
0
0
(3013512) EKG study
11
221
0.44
1.85
3.5
4.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
13
245
0.46
1.84
5.8
4.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
20
324
0.53
1.80
4.0
4.1
ng/l
49.4
56.5
0.15
13
242
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
18
3.47
1.77
1.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
46
0.00
1.75
0.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
7
160
0.40
1.73
5.3
2.6
ug/l
1.1
0.9
—
7
114
(3021960) Folate [Moles/volume] in Serum or Plasma
10
196
0.46
1.56
1.6
1.6
nmol/l
23.4
19.1
—
10
165
(3012095) Magnesium [Moles/volume] in Serum or Plasma
17
96
1.92
1.50
3.0
2.1
mmol/l
0.8
0.8
0.10
17
89
(3015736) pH of Urine
16
257
0.55
1.35
4.7
3.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
25
2.48
1.26
1.8
3.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
45
2.09
1.08
16.3
8.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
29
0.00
0.99
0.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
32
0.00
0.97
0.0
2.4
—
80.5
—
0
24
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
37
1.95
0.96
18.9
7.3
%
0.7
1.4
—
7
37
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
37
1.95
0.96
19.1
7.2
%
0.5
0.8
—
7
37
(40768804) Tissue Pathology biopsy report
26
188
1.51
0.95
3.0
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
14
90
1.64
0.83
2.8
1.6
—
—
—
0
0
(4034850)
0
24
0.00
0.80
0.0
15.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
1.4
—
36.0
—
0
20
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
27
0.00
0.78
0.0
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
17
237
0.66
0.78
4.8
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
7
38
1.90
0.75
1.7
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
26
1.97
0.71
21.8
6.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
18
237
0.71
0.61
2.5
2.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
136
1.39
0.53
8.7
5.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
11
155
0.68
0.53
4.3
3.4
ng/l
209.1
186.1
0.04
11
126
(3018677) aPTT in Platelet poor plasma by Coagulation assay
7
109
0.62
0.52
2.3
1.6
s
28.9
30.1
—
7
104
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
7
48
1.49
0.48
1.1
2.1
g/l
0.2
0.2
—
7
33
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
50
1.43
0.46
1.6
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
25
300
0.78
0.45
5.5
5.5
%
10.2
9.0
0.87
25
269
(3014111) Lactate [Moles/volume] in Serum or Plasma
8
55
1.49
0.44
20.4
5.2
mmol/l
1.1
1.5
—
8
50
(3023368) Bacteria identified in Blood by Culture
24
197
1.28
0.43
5.7
3.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
23
277
0.78
0.42
4.4
3.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
15
0.00
0.41
0.0
2.4
—
105.5
—
0
15
(3041354) Potassium [Moles/volume] in Venous blood
0
15
0.00
0.41
0.0
2.4
—
4.1
—
0
15
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
15
0.00
0.41
0.0
6.1
—
105.6
—
0
15
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3039000) Anion gap in Blood
0
15
0.00
0.41
0.0
6.1
—
9.8
—
0
15
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(4094501)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
25
297
0.79
0.41
5.5
5.2
%
3.0
2.9
0.01
25
266
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
35
1.45
0.40
2.8
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
81
1.40
0.38
1.5
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
5
78
0.62
0.37
2.0
2.2
e9/l
74.3
63.2
—
5
66
(3002030) Lymphocytes/100 leukocytes in Blood
26
302
0.82
0.35
5.3
5.4
%
22.8
25.5
0.69
26
268
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
88
0.66
0.34
12.8
9.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
25
291
0.82
0.34
5.5
5.1
%
0.8
0.6
0.49
25
262
(42870588) Differential panel, method unspecified - Blood
18
217
0.79
0.33
5.2
5.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
7
98
0.69
0.32
5.7
2.5
%
24.7
23.0
—
7
89
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
18
216
0.80
0.32
2.1
2.0
u/l
68.7
60.4
0.48
18
195
(3018010) Neutrophils/100 leukocytes in Blood
26
298
0.83
0.30
5.3
5.0
%
58.8
59.2
0.05
26
267
(3012544) pH of Venous blood
5
72
0.68
0.27
6.6
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
72
0.68
0.27
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
73
0.67
0.27
2.6
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
15
180
0.81
0.27
3.4
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
16
188
0.82
0.23
3.7
2.7
u/l
27.5
31.4
0.80
16
175
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
41
1.23
0.22
3.8
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
12
0.00
0.21
0.0
2.6
—
58.0
—
0
12
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
12
0.00
0.21
0.0
2.0
—
16.6
—
0
7
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
115
0.76
0.21
4.9
4.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
3.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
2.4
—
495.6
—
0
9
(3032080) INR in Blood by Coagulation assay
26
288
0.87
0.20
7.4
10.8
inr
1.4
1.4
—
8
81
(3002032) Base excess in Venous blood by calculation
5
68
0.72
0.17
6.6
4.2
mmol/l
2.2
1.8
—
5
54
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
8
68
1.19
0.17
2.0
2.3
umol/l
4.3
8.0
—
8
58
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
77
0.77
0.16
2.8
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
140
1.17
0.16
3.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
77
1.18
0.16
1.9
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
77
1.18
0.16
1.9
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
16
145
1.12
0.10
6.4
3.1
%
91.7
82.9
0.86
16
138
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
48
1.04
0.09
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
62
0.80
0.08
1.0
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
5
62
0.80
0.08
1.6
2.0
u/l
37.8
33.4
—
5
49
(3002173) Hemoglobin [Mass/volume] in Arterial blood
7
63
1.12
0.08
18.9
6.6
g/l
110.7
121.6
—
7
63
(3000494) Fungus identified in Specimen by Culture
6
70
0.85
0.08
1.2
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
91
0.87
0.07
1.4
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
20
190
1.07
0.04
3.3
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
14
149
0.93
0.03
1.3
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
30
307
0.97
0.01
12.2
4.9
mmol/l
1.2
1.2
0.28
30
266
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
142
0.98
0.00
5.7
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
114
0.96
0.00
1.8
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.2
—
2.6
—
0
5
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
2570.0
—
0
5
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.1
—
10.1
—
0
7
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
59
0.84
0.00
3.0
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.5
—
6.2
—
0
6
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
26.6
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
17.5
—
0
5
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
6
67
0.89
0.00
2.5
3.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
1.7
—
0
5
(4062490)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
19.4
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
8
0.00
0.00
0.0
1.4
—
34.4
—
0
8
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC – Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).